drugset / Trial / NCT00656474
Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study is intended to evaluate safety and efficacy parameters in patients treated with GLYC-101 gel or placebo after laser ablation.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-04
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | beta-glucan | Other / unclassified | 1 % | Topical |
Indications
No indication recorded.